相关实验视频
Updated: Jan 12, 2026

07:02
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
Published on: January 19, 2019
6.8K
在早期痴呆症的生存率和死亡率
Kasper Katisko1, Mikko Aaltonen2, Kalle Aho1
1Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio, Finland.
Journal of neurology, neurosurgery, and psychiatry
|November 4, 2025
概括
早期痴呆症 (EOD) 显著降低了存活率,而前性痴呆症 (FTD) 和α-synucleinopathy (α-SYNU) 显示出最短的预后. 与对照组相比,EOD患者的死亡风险要大得多.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 在65岁之前诊断的早期痴呆症 (EOD) 造成了重大的社会经济负担.
- 关于特定于EOD的生存和预后因素的研究有限.
研究的目的:
- 评估EOD患者的生存率和死亡风险.
- 确定影响不同EOD亚型预后的因素.
主要方法:
- 在芬兰 (2010-2021) 的794个经过验证的EOD病例中进行了基于人口的队列研究.
- 包括阿尔茨海默病 (AD),前性痴呆症 (FTD) 和α-synucleinopathy (α-SYNU) 在内.
- 与7930个来自一般人口登记册的对照进行了匹配.
主要成果:
- 平均EOD存活时间为8.7年;FTD (6.9年) 和α-SYNU (7.0年) 的存活时间最短.
- EOD患者的死亡风险比对照患者高6.56倍 (p<0.001).
- 在FTD患者中,死亡风险最高 (HR=13.75,p<0.001).
结论:
- EOD诊断显著影响患者的生存率.
- 在EOD亚型和人口统计因素之间,生存率差异很大.
相关概念视频
Actuarial Approach
283
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
283
Dementia
508
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
508
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Hazard Rate
395
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
395
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
Cancer Survival Analysis
639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639

